In Q3FY21, its cumulative disbursements went beyond Rs 2,000 crore. In the same quarter, the value of AUM stood at Rs 1,127 crore, which is a 15 per cent increase over its previous quarter.

Industrial biotechnology company, Praj Industries Ltd announced on Tuesday that it has bagged a prestigious breakthrough order to set up compressed biogas (CBG) project from Hindustan Petroleum Corporation Limited (HPCL).

The Ahmedabad-based company informed the bourses that it has received a letter of acceptance (LoA) amounting to Rs 1,491.34 crore (exclusive of GST) to construct medical colleges and hospitals at multiple locations in Uttar Pradesh.

The company’s marketing partner BPI will launch Everolimus tablets in the strengths of 2.5 mg, 5 mg, and 7.5 mg in the near term.

The company received the order for waste heat recovery boilers from the cement industry while its capacity makes it the largest in the world.

The company has received the order from Bharat Sanchar Nigam Limited (BSNL) for the commissioning of point-to-point links.

This is a strategic acquisition as the location of GPL in the north of Andhra Pradesh complements the company’s recent acquisition of the Port of Krishnapatnam that serves the south of AP.

The company announced the addition of two residential plots in Sanpada (Navi Mumbai) from City & Industrial Development Corporation (CIDCO).

The subsidiary of Biocon Ltd i.e. Biocon Biologics announced on Monday that it has received CHMP approval to market Abevmy, which is a biosimilar to Avastin.

The company has approved the proposal for the buyback of fully paid-up equity shares for an aggregate amount, not exceeding Rs 150 crore, which is 5.05 per cent of the total paid-up equity share capital.

The drug may help improve mood and feelings of well-being, relieve anxiety and tension as well as increase energy level.

The drug will be manufactured in the company’s Hyderabad facility, which is expected to be launched in the near term.

This collaboration also aims to enable a faster rollout of broadband services in a cost-effective and expeditious manner across India.

With this acquisition, the company will be able to distribute over 25 billion units of power as against the earlier capacity of 16.66 billion to nearly 3.8 million customers compared to the earlier customer base of 3.65 million. 

The company has proposed a buyback of not exceeding 6,97,56,641 fully paid-up equity shares at a price of Rs 150 per equity share on a proportionate basis, through the tender offer process.

Wabag will execute the EPC portion of this project over a period of 24 months, followed by operation & maintenance of 15 years. 

The company plans to invest over Rs 10,000 crore to develop DPL into an alternate gateway to Jawaharlal Nehru Port Trust (JNPT).

In order to realise its vision of modern luxury mobility with confidence, the company will closely undergo collaboration and knowledge-sharing with Tata Group companies, which will enable it to enhance sustainability and decrease emissions as well as sharing best practice in the next-generation technology, data & software development leadership.

BankservAfrica’s customers will benefit from a secure, real-time and scalable solution for account information by leveraging TCS’ innovative Quartz Smart Ledgers for proxy resolution, built on a decentralised/distributed architecture. 

It has now become a major success as its customers are looking to go digital. The concept gained popularity and became more relevant in the post-pandemic world, paving way for the company’s strong growth. 

The company received ANDA approval by United States Food & Drug Administration (USFDA) for Clindamycin Phosphate Gel USP 1 per cent, which is the generic version of Cleocin T 1 Gel, 1 per cent, of Pharmacia & Upjohn. 

The company signed a share purchase and shareholders agreement with IGX and Indian Energy Exchange Limited, the promoter & parent company of IGX.

The company plans brownfield expansion and debottlenecking project, coupled with the addition of balancing & ancillary equipment in Bhuj.

One of India's manufacturers of ammunitions and missile systems, Bharat Dynamics Ltd (BDL) announced during the weekend that it has launched two new products at Aero India 2021 namely, ‘Dishani’ and ‘Garudastra’. 

The company anticipates bringing products based on CTPR in near term that would be affordable and accessible to farmers across India. 

The company will leverage policy initiatives of the Indian Government, such as ‘Make in India’ to offer affordable healthcare for the country. 

A leading global technology company, HCL Technologies Ltd announced on Thursday that the company has inked a five-year agreement with Airbus for digital workplace services.

The company informed that it has received a letter of intent (LoI) from a private developer in Ahmedabad (Gujarat) for a project worth Rs 588.62 crore (including GST).

Subscription, being a new concept in India, the company received overwhelming response in the past few months in the form of over 15,500 enquiries. 

Glenmark Pharmaceuticals Limited announced on Wednesday that the company has received final approval from United States Food & Drug Administration (USFDA). Reacting to the news, its share rose nearly 2 per cent on BSE.

The Finance Minister announced a sharp increase in the capital expenditure of nearly 34.5 per cent to Rs 5.54 lakh crore for FY 2022 as against Rs 4.39 lakh crore.

Considering the latest order, the order pipeline of Tata Power Solar Systems Ltd (TPSSL) stands at approximately 4.2 GWp with an approximate value of Rs 12,500 crore thus, strengthening the company’s position as India’s leading solar EPC player for the seventh year in a row among utility-scale. 

The home textiles manufacturer strengthened its retail presence in the country with the opening of six new exclusive showrooms for its bed & bath linen brands.

The product is bioequivalent and therapeutically equivalent to Actigall capsules, 300 mg, of Allergan Sales, LLC. The US market for the capsule is approximately USD 45 million, according to IQVIA MAT November 2020 data.

The company’s card-in-force increased by 15 per cent to 1.15 crore in December 2020 quarter as compared to 1 crore in the corresponding quarter of the previous year, suggesting a revival in the business.

The first shipment of Jimny, consisting of 184 units, left from Mundra port to Latin American countries like Columbia and Peru.

The clients of Ramco Systems will benefit from the real-time view of their logistics operations using HERE maps after embedding geo-visualisation layer provided by HERE. 

The new orders worth Rs 250 crore are to be executed over the next 5 months.

The agreement includes six injectable products to be filed shortly in Canada, of which, some of the products have already been filed by Caplin Steriles in the USA, a subsidiary of Caplin Point Laboratories Limited.

The cash consideration will be funded through internal accruals and debt of up to Rs 300 crore. It will also issue up to 4,95,000 equity on a preferential basis. 

The company has bagged orders for over 26,000 wheels amounting to EUR 2,06,000, which is to be executed in the month of March 2021 from its Chennai plant. 

The scope of work involves filling of tanks in Kalaburgi for groundwater development & drinking water purposes.

The project costs Rs 51.60 crore with an execution period of 6 months from the date of commencement.

LTI will leverage IBM Cloud offerings to help clients migrate and modernise core business applications. 

The new order, worth Rs 450 crore, is for NALCO’s fifth stream alumina refinery expansion project at Damanjodi (Odisha).

The price increase was mainly due to unprecedented increase in commodity prices and various other input costs. 

The company recorded the best ever quarterly sales volume without any major launch during the quarter.

The company has received orders worth Rs 632.88 crore for Konkurs-M anti-tank guided missile (ATGM) along with launchers and test equipment.

The company will also carry out the maintenance of entire project stretch design length of 109.27 km for 7 years in the state of Tamil Nadu on engineering, procurement & construction (EPC) mode.

The company will begin phase 3 clinical trial in around 30,000 volunteers. The launch of phase 3 will help to determine the effectiveness of the vaccine in preventing COVID-19. 

The company has received fifteen new orders from central or state government agencies in the month of December 2020.

According to the contract, the company is set to supply and install an ultra-converged broadband product.

Additionally, the company has also received tentative approval for Apremilast tablets. 

Saroglitazar Mg is the first medicine used for the treatment of NAFLD. This approval for NAFLD, along with either of the co-morbidities (obesity, type 2 Diabetes Mellitus, Dyslipidemia) would provide physicians with a viable treatment option.  

The launch of Tacrolimus capsules expands Biocon’s generic formulation portfolio in the US. 

Moreover, the company will provide an enhanced full-service enterprise mobility solution to customers through complete access and management of eSIM & software layer. 

Under this agreement, Glenmark Pharma will be responsible for the development & regulatory approval of the nasal spray by relevant European Regulatory Authorities whereas, Menarini Group will be responsible for the commercialisation of Ryaltris across these markets. 

With this strategic acquisition, Firstsource Solutions will be able to strengthen its presence in large markets like Texas and New York, coupled with new capabilities of pre-authorisation and patient bill estimation at the front-end of the RCM cycle.  

The EPC project is regarding the construction of eight-lane access-controlled expressway in the section of Delhi-Vadodara greenfield alignment under Bharatmala Pariyojana in the state of Rajasthan.

The civil engineering company will construct an elevated viaduct of 11.6 km from Kadarshani Nal (Gujarat) to Dream City Dead End for Surat Metro Rail Project Phase-1.  The project is worth Rs 779.73 crore with a construction period of 30 months. 

The digital lending platform is designed to aid lenders in rapidly expanding business operations as well as generating digital revenue streams by targeting new customer segments. 

Rufinamide oral suspension 40 mg/ml is a generic equivalent of Banzel oral suspension of Eisai Inc, which is used in the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in pediatric patients of age one year and older. 

The company received LOA for pipe drinking water schemes from Namami Gange & Rural Water Supply Department in the state of Uttar Pradesh. 

The promoter plans to sell 2,40,00,000 equity shares of the company with an option to additionally sell 80,00,000 shares. The company has set a floor price of Rs 1,367 per share for the sale.

The company will manufacture Dexmedetomidine Hydrochloride in 0.9 per cent Sodium Chloride injection, in the strengths of 200 µg/50 ml and 400 µg/100 ml single doses in flexible containers (bags). The injection is said to launch in January 2021.

Bengaluru is a key market for the company and the project would help the company to deepen its presence across the country's leading real estate markets.

In phase 1 clinical trial, the company will study the safety, tolerability, pharmacokinetics, and pharmacodynamics of ZYIL1 in healthy human volunteers.

The manufacturing of the drug will take place at the company’s manufacturing facility in Chantilly (Virginia) and its launch is expected soon.

The company has made an investment of Rs 5,477 crore for the expansion. Upon completion, the company’s capacity will increase to 136.25 MTPA, making it the third-largest company in the world, outside China.

The company has received an order worth Rs 3,905 crore exclusive of GST in the month of November. Out of the four orders, one belongs to the water division amounting to Rs 848 crore and the remaining three orders belong to the building division worth Rs 3,057 crore. 

The company has received an order worth Rs 1,000.72 crore from Water Resources Department, Government of Andhra Pradesh, on November 30, 2020.

It is a generic version of Tenoretic Tablets of Alvogen Malta Operations Limited. The drug is used in the treatment of hypertension, to lower blood pressure. 

On the domestic front, the company registered a growth of 30.9 per cent YoY to 9,662 tractors as against 7,379 tractors in the corresponding month of the previous year. 

The agreement would help Laurus Labs in adding a fourth revenue stream to its existing revenue stream of active pharmaceutical ingredient (API), formulations, and synthesis.

The contract is to construct the country’s longest road bridge across the River Brahmaputra connecting Dhubri (Assam) to Phulbari (Meghalaya). It will be a 19 km long bridge, which would be built alongside National Highway 127-B.

The steel wheel producer confirmed that it has received an export order for nearly 62,000 wheels for the United States & European Union market amounting to USD 8,78,000.

Ircon International, formerly known as Indian Railway Construction Limited, earns 85.1 per cent from railways, 12.6 per cent from highways, and 2.3 per cent from other services.

The pharmaceutical company headquartered in Bengaluru, Strides Pharma Science Limited announced today that its subsidiary, Strides Pharma Global Pte Limited (Singapore) has received a nod for Prednisone tablets USP from United States Food & Drug Administration (USFDA).

The telecom operator received a cash consideration of Rs 3,760.1 crore after it sold its stake of 11.15 per cent in Indus Tower. 

The company brings an integrated solution that can meet the demands of rigorous and expansive vaccine management programs.

This strategic collaboration brings together Syngene’s integrated drug discovery (IDD) services and skills of Deerfield’s drug discovery and development arm 3DC. 

With execution of share purchase agreement and completion of sale November 18, 2020, GTPL Space City has ceased as subsidiary of the company.

With extensive reach, partnership and network with the public health authorities and other institutions, Cipla will be ensure uninterrupted access of these kits across more than 25 markets in Asia, Australia, Europe, Middle East, North Africa and Latin America.

The strategic collaboration includes software development and integration. It also covers maintenance of the combined powertrain coordination units including charging control.

Blue Star Limited is experiencing a gradual increase in the inflow of orders for bundled services. Presently, this order is one of the largest and fast-track projects, which is being executed by Blue Star in the factories’ segment.

The mineable reserve block is 1,091 million metric tonnes, which is to be exploited for a period of 25 years at a peak rated capacity of 50 million tonnes per annum.

The MoU would help to create a market for pre-engineered steel buildings made from structural steel tubes, which is consistent with APL’s strategy to create new markets for structural steel tubes in India.  

The yearly business from the new US customer is expected to realise approximately USD 10 million in the current financial year.The new business relationship will support the company in maintaining full capacity production at its Chennai steel wheels’ plant.

With this partnership, Dr Reddy’s Laboratories can identify and use some of BIRAC’s clinical trial centres for the vaccine, which are funded under National Biopharma Mission (NBM) at BIRAC.

Under this collaboration, TCS will help Equinor to speed up its digitalisation process and enable it realise the vision of becoming a digital energy company.

The company is evaluating and concluding strategic options towards focussed portfolio enhancement with the ultimate objective of enhancing stakeholder values.

The fashion & lifestyle company plans to use the capital to strengthen its balance sheet and speed up its growth trajectory. 

The company’s payroll solution, powered with platform-driven automation, provides accurate regional payroll, improved payroll readiness coupled with optimised processing time provides enhanced user experience at Lendlease.

Commercial and residential spaces arm of buildings & factories business bagged orders from reputed developers to construct a residential project and an office space in Mumbai.

The drug company will market Solifenacin Succinate tablets (Vesicare tablets) in the strengths of 5 mg and 10 mg, which is used in the treatment of overactive bladder syndrome.

As a part of the contract, Wipro will manage Fortum’s application portfolio across hundreds of applications for more than 11,500 users from 18 countries and provide 24-hour support for business-critical applications.

Sirolimus tablets, 0.5 mg, 1 mg, and 2 mg are the generic version of Rapamune tablets, 0.5 mg, 1 mg, and 2 mg, of PF Prism CV. These tablets are used to prevent the rejection of kidney transplants.

Dr Reddy’s and RDIF entered into a partnership in early September 2020 to conduct clinical trials and distribution of Sputnik V vaccine in India and as a part of it, RDIF would be delivering 100 million doses of the vaccine to Dr Reddy’s after receiving regulatory approval in India.

The drug is indicated for the prophylaxis of signs and symptoms of infection caused by various strains of influenza A virus and is also used in the treatment of parkinsonism and drug-induced extrapyramidal reactions.

Acalabrutinib 100 mg capsules (Calquence) are used to treat patients suffering from mantle cell lymphoma (MCL) especially those, who have received at least one prior therapy. It is also used for the treatment of chronic lymphocytic leukaemia (CLL)/small lymphocytic lymphoma (SLL).